Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Citric acid is an anti-chelation additive used in blood collection tubes and as a flavoring and preservative agent in various cosmetic and pharmaceutical products. A key intermediate in metabolism.
- Mechanism
- Curator reviewed
Pharmacologically active on Metallo-beta-lactamase type 2, Aldo-keto reductase family 1 member B1, and Isocitrate dehydrogenase [NADP]
- Formula / weight
- C6H8O7 · 192.1235 g/mol (avg)
- First approval
- Canada, 1998 · United States, 1980
- Also known as
- Anhydrous citric acid · Citrate · Citric acid monoglyceride · Citric acid, anhydrous
- Code names
- FEMA NO. 2306 · NSC-112226 · NSC-30279 · NSC-626579
Resolves to
Clinical / RWD
Structure
InChIKey
KRKNYBCHXYNGOX-UHFFFAOYSA-NSMILESOC(=O)CC(O)(CC(O)=O)C(O)=OTransporters
What you can answer from here — as of September 23, 2026
52Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Citric acid, and which of those have an active Phase 3 trial?